Stem cell niche, the microenvironment and immunological crosstalk

Cellular and Molecular Immunology

Volumn 5, Issue 2, 2008, Pages 107-112

  Sujata, Law ^a   Chaudhuri, S ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

stem cell niche; stromal immunology

Indexed keywords

ADULT STEM CELL; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; REVIEW; STROMA CELL;

ADULT STEM CELLS; CELL PROLIFERATION; STROMAL CELLS;

EID: 44949243178     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.13     Document Type: Review

References (69)

1. Weissman IL. Stem cells: Units of development, units of regeneration, and units in evolution. Cell. 2000;100:157-168. (Pubitemid 30046304)
2. Morrison SJ, Kimble J. Asymmetric and symmetric stem cell divisions in development and cancer. Nature. 2006;444:1068-1074. (Pubitemid 43990718)
3. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. 2001;414:105-111.
4. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem cell biology to cancer. Nat Rev Cancer. 2003;3:895-902. (Pubitemid 37500174)
5. Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441:1075-1079. (Pubitemid 43990719)
6. Kiger AA, Jones DL, Schulz C, Rogers MB, Fuller MT. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science. 2001;294:2542-2545. (Pubitemid 34027293)
7. Xie T, Spradling AC. A niche maintaining germ line stem cells in the drosophila ovary. Science. 2000;290:328-330.
8. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbours: stem cells and their niche. Cell. 2004;116:769-778. (Pubitemid 38410723)
9. Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006; 116:1195-1201.
10. Powell K. Its the ecology, stupid! Nature. 2005;435:268-270.
11. Li L, Neaves WB. Normal stem cells and cancer stem cells. Cancer Res. 2006;66:4553-4557.
12. Rizo A, Vellenga E, Haan G, Schuringa JJ. Signaling pathways in self-renewing haematopoietic and leukaemic stem cells: do all stem cells need a niche? Human Mol Genetics. 2006;15: 210-219.
13. Flynn CM, Kaufman DS. Donor cell leukaemia: insight into cancer stem cells and the stem cell niche. Blood. 2007;109: 2688-2692. (Pubitemid 46482059)
14. Baguley BC. Tumor stem cells niches: A new functional framework for the action of anticancer drugs. recent patents on anti-cancer drug discovery. 2006;1:121-127.
15. Huntly BJP, Gilliland DG. Leukaemia stem cells and the evolution of cancer stem cell research. Nat Rev. 2005;5:311-321. (Pubitemid 40488636)
16. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Eng J Med. 2006;355:1253-1261. (Pubitemid 44427449)
17. Bianco P, Riminucci M. The bone marrow stroma in vivo: ontogeny, structure, cellular composition and changes in disease. In: Beresford JN eds. Marrow stromal cell culture. United Kingdom: Cambridge University Press; 1998:10-25.
18. Ryan DH, Nuccie BL, Abboud CN, Winslow JM. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of Human B cell precursors to cultured bone marrow adherent cells. J Clin Invest. 1991;88:995-1004.
19. Dittel BN, Mc Carthy JB, Wayner EA, LeBien TW. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood. 1993; 81:2272-2282. (Pubitemid 23127061)
20. Watt FM, Hogan BLM. Out of eden: Stem cells and their niches. Science. 2000;287:1427-1430. (Pubitemid 30127126)
21. Horwitz EM, Keating A. Nonhaematopoietic mesenchymal stem cells: What are they? Cytotherapy. 2000;2:387-388. (Pubitemid 32117773)
22. Blau HM. Brazelton TR, Weiman JM. The evolving concept of a stem cell: Entity or Function? Cell. 2001;105:829-841. (Pubitemid 32635085)
23. Zwaka TP, Thomson JA. A germ cell origin of embryonic stem cells? Development. 2005;132:227-233. (Pubitemid 40268273)
24. Law S, Chaudhuri S. Niche theory, stem-stromal imbalance and aplastic anaemia. J Stem Cells. 2007;2:1-10.
25. Law S, Maiti D, Palit A, Chaudhuri S. Role of biomodulators and involvement of protein tyrosine kinase on stem cell migration in normal and Leukaemic mice. Immunol Let. 2003; 86:287-290. (Pubitemid 36432096)
26. Rattis F M, Voermans C, Reya T. Wnt signaling in the stem cell niche. Curr Opin Haematol. 2004;11:88-94. (Pubitemid 38951226)
27. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signaling in self renewal of haematopoietic stem cells. Nature. 2003;423: 409-414. (Pubitemid 36626987)
28. Zang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425:836-841. (Pubitemid 37351467)
29. Mannelo F. Multipotent mesenchymal stromal cell recruitment, migration, and differentiation: what have matrix metalloproteinases got to do with it? Stem Cells. 2006;24:1904-1907.
30. Adams GB. Stem engraftment at the endosteal niche is specialized by the calcium sensing receptor. Nature. 2006;439: 599-603. (Pubitemid 43185384)
31. Li L, Xie T. Stem cell niche structure and function. Annu Rev Cell Dev Biol. 2005;21:605-631. (Pubitemid 41740648)
32. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature. 2001;414:98-104. (Pubitemid 33041633)
33. Lin H. The stem cell niche theory: lessons from flies. Nat Rev Genet. 2002;3:931-940. (Pubitemid 35423505)
34. Schofield R. The relationship between the spleen colony forming cell and the haemopoietic stem cell. Blood Cells. 1978;4:7-25. (Pubitemid 8376317)
35. Rios M, Williams DA. Systematic analysis of the ability of stromal cell lines derived from different murine adult tissues to support maintenance of haematopoietic stem cells in vitro. J Cell Physiol. 1990;145:434-443. (Pubitemid 120027381)
36. Haylock DN, Nilsson SK. Stem cell regulation by the haematopoietic stem cell niche. Cell Cycle. 2005;4:1353-1355. (Pubitemid 41437120)
37. Ohlstein B, Kai T, Decotto E, Spradling A. The stem cell niche. Theme are variations. Curr Opin Cell Biol. 2004;16:693-699. (Pubitemid 39463122)
38. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001;226:507-520. (Pubitemid 32524497)
39. Adams GB, Scadden DT. A niche opportunity for stem cell therapeutics. Gene Therapy. 2007;13:1-4.
40. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49. (Pubitemid 34742565)
41. Owen ME. The marrow stromal cell system. In: Beresford J N eds. Marrow stromal cell culture. United Kingdom: Cambridge University Press; 1998:1-9.
42. Owen ME. Lineage of osteogenic cells and their relationship to the stromal system. In: Peck W A eds. Bone and Mineral research. Amsterdam: Elsevier; 1985:1-25.
43. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Haematol. 2000;28:875-884.
44. Law S, Basu K, Banerjee S, Begum B, Chaudhuri S. Cord blood derived plasma factor (CBPF) potentiated the low cytokinetic and immunokinetic profile of bone marrow cells in pesticide victims suffering from Acquired Aplastic Anaemia (AAA) An in vitro correlate. Immunol Invest. 2006;35:209-225.
45. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284:143-147. (Pubitemid 29282067)
46. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a Hierarchial model. J Cell Sci. 2000;113:1161-1166. (Pubitemid 30229533)
47. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The international society for cellular therapy position statement. Cytotherapy. 2005;7:393-395. (Pubitemid 41671625)
48. Zipori D. Mesenchymal stem cells: Harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis. 2004;33:211-215. (Pubitemid 39446488)
49. Rizvi AZ, Wong MH. Epithelial stem cells and their niche: Theres no place like home. Stem Cells. 2005;23:150-165. (Pubitemid 40239512)
50. Silva WA Jr, Covas DT, Panepucci RA, et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells. 2003;21:661-669. (Pubitemid 37329159)
51. Panepucci RA, Siufi JLC, Silva WA Jr, et al. Comparison of gene expression of umbilical cord vein and bone marrow derived mesenchymal stem cells. Stem Cells. 2004;22:1263-1278. (Pubitemid 39646504)
52. Cronmright G, Le Blanc K, Gotherstrom C, Uzunel M, Lahesmaa R, Le Blanc K. Cancer/Testis antigen expression in human mesenchymal stem cells: Downregulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res. 2005;65:2207-2215. (Pubitemid 40490129)
53. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24:1030-1041. (Pubitemid 44464736)
54. + bone marrow cells regulate stromal production of interleukin-6 and granulocyte-colony-stimulating-factor and increase the colony stimulating activity of stroma. Blood. 1998;91:3724-3733. (Pubitemid 28225740)
55. Basu K. Structure-function correlationship of the pluripotent cells of bone marrow in health and disease: An immunological approach towards the haematopoietic microenvironment versus biological response modifiers. Ph.D. Thesis. 2003. Jadavpur University. Kolkata. India.
56. Weiss L. The haematopoietic microenvironment of bone marrow: An ultrastructural study of the stroma in rats. Anat Rec. 1976;186:161-184.
57. Weiss L, Sakai H. The haematopoietic stroma. Am J Anat. 1984; 170:447-463.
58. Kaplan RN, Psaila B, Lyden D. Niche-to-niche migration of bone marrow derived cells. Trends Mol Med. 2007;13:72-81. (Pubitemid 46201791)
59. Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest. 2003;112:147-149. (Pubitemid 38056349)
60. Chellaiah MA. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell. 2003;14:173-189. (Pubitemid 36106028)
61. Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodelling. J Cell Biochem. 1998;30:92-102. (Pubitemid 29028730)
62. Stier S, Ko Y, Forkert R, et al. Osteopontin is a haematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med. 2005;201:1781-1791. (Pubitemid 41002897)
63. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor ligand interaction between CD44 and osteopontin (ECA-1). Science. 1996;71:509-512. (Pubitemid 26044470)
64. Jansson M, Panoutsakopoulou V, Baker J, Klein L, Cantor H. Attenuated experimental autoimmune encephalomyelitis in ECA-1/Osteopontin deficient mice. J Immunol. 2002;168:2096-2099. (Pubitemid 34171807)
65. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: Home of HSC differentiation and mobilization. Physiology. 2005;20:349-356. (Pubitemid 41457400)
66. Law S, Maiti D, Palit A, et al. Facilitation of functional compartmentalization of bone marrow cells in leukaemic mice by biological response modifiers: An immunotherapeutic approach. Immunol Let. 2001;76:145-152. (Pubitemid 32295934)
67. Law S, Chaudhuri S. Characterization and ex vivo manipulation of bone marrow derived CD34 positive cells: An immunological approach towards cytotherapy. Transplantation India. 2002;1: 55-56.
68. Law S, Begum B, Chaudhuri S. Pluripotent bone marrow cells in leukaemic mice elicit enhanced immune reactivity following sheep erythrocyte administration in vivo. J Exp Clin Cancer Res. 2003;22:421-429.
69. Chaudhuri S, Law S. Stem cells and frontiers of therapeutic advances in cancer. J Exp Clin Cancer Res. 2005;24:207-215.